Werfen and Instrumentation Laboratory acquire Accriva Diagnostics
Werfen and its subsidiary Instrumentation Laboratory acquired all shares of Accriva Diagnostics, a point-of-care diagnostic company. The transaction closed on January 19, 2017. Accriva will operate from its San Diego facility.
Productspoint-of-care diagnostic products for coagulation and anti-platelet therapy response
“Accriva Diagnostics, a Warburg Pincus portfolio company, announced today the definitive agreement with Werfen... whereby Werfen and IL have acquired all shares of Accriva.”baycitycapital.com
- 3 sources
- baycitycapital.comAccriva Diagnostics Acquired by Werfen and Instrumentation Laboratory - Bay City CapitalJan 20, 2017
- biospace.comWerfen Group Release: Company And Instrumentation Laboratory Company Acquire Accriva Diagnostics, Expanding Leadership In Point-Of-Care Testing - BioSpaceAnnalee ArmstrongJan 20, 2017
- nsmedicaldevices.comWerfen, Instrumentation Laboratory acquire Accriva Diagnostics - NS Medical DevicesJan 23, 2017
Summarized from public sources; check the original articles before acting on it.
ENDATA